Artenimol clinical trials
Also written Dihydroartemisinin.
How each study uses artenimol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the artenimol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 27 Oct 2011 · Eurartesim · EMEA/H/C/001199 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
91 studies that test it; most in 2010 (9)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 9 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 8 |
| 2014 | 6 |
| 2015 | 6 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 84
University of California, San Francisco (7) · London School of Hygiene and Tropical Medicine (7) · University of Oxford (7) · Liverpool School of Tropical Medicine (6) · Shanghai Zhongshan Hospital (4) · National Institute for Medical Research, Tanzania (4) · sigma-tau i.f.r. S.p.A. (3) · University of North Carolina, Chapel Hill (2)
Often tested with
Tested in the same studies.
Piperaquine (83) · Fanasil, pyrimethamine drug combination (10) · Artemether, Lumefantrine Drug Combination (10) · Amodiaquine (9) · Chloroquine (6) · Artesunate (5) · Primaquine (3) · Mefloquine (2)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test artenimol, phase 3 first.
- May 2027Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)Phase 3 · Grant Dorsey, M.D, Ph.D.
Studies
Open first, then newest update. How each study uses artenimol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 91
- Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community TransmissionRecruitingPhase 4University of California, San FranciscoNCT07246525Written as dihydroartemisinin-piperaquine
- Focal Mass Drug Administration for the Prevention of Malaria in PregnancyRecruitingEarly Phase 1University of North Carolina, Chapel HillNCT07021430Written as Dihydroartemisinin Piperaquine
- Dihydroartemisinin for MAFLDRecruitingPhase 1/2The First Affiliated Hospital with Nanjing Medical UniversityNCT07679542Written as Dihydroartemisinin
- A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus ErythematosusNot yet recruitingPhase 2Kunming Pharmaceuticals, Inc.NCT07557927Written as Dihydroartemisinin tablets
- Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium VivaxNot yet recruitingNot applicableWalter Reed Army Institute of Research (WRAIR)NCT07533136Written as Dihydroartemisinin-piperaquine (DHA-PPQ)
- Perennial Malaria Chemoprevention in the Malaria Vaccine EraNot yet recruitingPhase 4Stanford UniversityNCT07322068Written as Dihydroartemisinin Piperaquine
- Safety of Antimalarials in the FIRst trimEsterRecruitingPhase 3Liverpool School of Tropical MedicineNCT06962319Written as dihydroartemisinin-piperaquine (DP)
- Efficacy of Dihydroartemisinin for Treating Acne VulgarisRecruitingEarly Phase 1Shanghai Zhongshan HospitalNCT07007078Written as dihydroartemisinin
- Dihydroartemisinin for the Treatment of Polycystic Ovary SyndromeRecruitingPhase 2Shanghai Zhongshan HospitalNCT06842524Written as Dihydroartemisinin
- Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina FasoRecruitingPhase 3Malaria ConsortiumNCT05946642Written as Dihydroartemisinin/Piperaquine (DP) plus Ivermectin (IVM)
- IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe FloodingActive, not recruitingNot applicableUniversity of North Carolina, Chapel HillNCT06870344Written as Dihydroartemisinin piperaquine
- CapeOx Combined With Anti-PD1 Antibody Plus Dihydroartemisinin as Neoadjuvant or Conversion Therapy for Microsatellite Stable Locally Advanced and Metastatic Colorectal CancerActive, not recruitingPhase 2Shanghai Changzheng HospitalNCT07801352Written as Dihydroartemisinin
- Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, MalawiCompletedPhase 4Liverpool School of Tropical MedicineNCT06083688Written as Dihydroartemisinin-Piperaquine
- The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination TherapyCompletedPhase 4Infectious Diseases Research Collaboration, UgandaNCT06347471Written as Dihydroartemisinin-Piperaquine
- Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)Active, not recruitingPhase 3Grant Dorsey, M.D, Ph.D.NCT04978272Written as Dihydroartemisinin-piperaquine (DP)
- Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of AntimalarialsActive, not recruitingPhase 2/3Johns Hopkins Bloomberg School of Public HealthNCT04009343Written as Dihydroartemisinin-piperaquine
- Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in UgandaCompletedPhase 3Grant Dorsey, M.D, Ph.D.NCT04336189Written as Dihydroartemisinin-piperaquine (DP)
- In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in MozambiqueCompletedPhase 4Centro de Investigacao em Saude de ManhicaNCT05343312Written as DHP
- Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in PregnancyActive, not recruitingPhase 3Menzies School of Health ResearchNCT05426434Written as Dihydroartemisinin-Piperaquine (DP)
- Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, EthiopiaActive, not recruitingPhase 3PATHNCT06516042Written as Dihydroartemisinin-piperaquine
See all 91 studies that test artenimol →
Given beside what is tested · 10 — artenimol is usual care or a partner of the new treatment
- Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated MalariaNot yet recruitingPhase 4Curtin UniversityNCT07403643Written as Dihydroartemisinin-piperaquine (DHA-PPQ)
- Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)CompletedPhase 2London School of Hygiene and Tropical MedicineNCT04609098Written as Dihydroartemisinin/Piperaquine
- Adjunctive Ivermectin Mass Drug Administration for Malaria ControlStatus unknownPhase 3London School of Hygiene and Tropical MedicineNCT04844905Written as Dihydroartemisinin-piperaquine
- Malaria Elimination Pilot Study in Military Forces in CambodiaStatus unknownPhase 4Armed Forces Research Institute of Medical Sciences, ThailandNCT02653898Written as DHA-PIP
- Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in CambodiaCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02612545Written as Dihydroartemisinin-piperaquine (DHA-PPQ)
- Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding StudyCompletedPhase 2Liverpool School of Tropical MedicineNCT02511353Written as dihydroartemisinin-piperaquine
- Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic CarriersCompletedPhase 3London School of Hygiene and Tropical MedicineNCT01838902Written as DHA-PPQ
- Delivery of Malaria Chemoprevention in the Post-discharge Management of Children With Severe Anaemia in MalawiStatus unknownPhase 3Kamuzu University of Health SciencesNCT02721420Written as dihydroartemisinin-piperaquine
- Safety and Tolerability of Low Dose PrimaquineCompletedPhase 4Malaria ConsortiumNCT02434952Written as Dihydroartemisinin piperaquine (DHA PP)
- Phase2a Primaquine Dose Escalation StudyCompletedPhase 2University of California, San FranciscoNCT01743820Written as dihydroartemisinin-piperaquine
As the comparator · 8 — what is tested is compared with artenimol
- Southeast Asia Dose Optimization of TafenoquineRecruitingPhase 4University of OxfordNCT04704999Written as Dihydroartemisinin 40 mg-Piperaquine 320 mg
- Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West PapuaCompletedPhase 2Syamsudin Abdillah,Ph.D, Pharm DNCT06036030Written as Dihydroartemisinin
- Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum MalariaCompletedPhase 1HuLowNCT02614404Written as Dihydroartemisinin-piperaquine
- Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum TransmissionCompletedPhase 2/3London School of Hygiene and Tropical MedicineNCT04049916Written as Dihydroartemisinin/Piperaquine
- Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant ParasitesStatus unknownPhase 2Nurex S.r.l.NCT03697668Written as Dihydroartemisinin-piperaquine
- Safety, Tolerability, Pharmacokinetics and Efficacy of ARCOCompletedPhase 4Ifakara Health InstituteNCT01930331Written as dihydroartemisinin/piperaquine phosphate
- Phase 2 Efficacy Study of Primaquine and Methylene BlueCompletedPhase 2University of California, San FranciscoNCT02831023Written as Dihydroartemisinin-piperaquine
- Assessment of Plasmodium Vivax Chloroquine Resistance in Cambodia:CompletedPhase 4Institut Pasteur, CambodiaNCT02118090Written as DHA-PP
What changed recently
From the registry's own updates since Oct 17, 2026.
Started recruiting1
Codes
What other systems call artenimol · ClinicalTrials.gg INT003114
- MeSH (NLM) C039060artenimolConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 6A9O50735XARTENIMOLConfirmed FDA, NLM
- NCI Thesaurus C87432ArtenimolOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C039060 | artenimol | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 6A9O50735X | ARTENIMOL | Confirmed FDA, NLM |
| NCI Thesaurus | C87432 | Artenimol | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.